Expand XPH Menu
XPH MENU

XPH ETF Profile


Family: State Street (SPDR)
Name: SPDR S&P Pharmaceuticals ETF
Inception Date: 19-Jun-2006
Termination Date:
Investment Objective: The SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the Index ).The S&P Pharmaceuticals Select Industry Index (the Index ) represents the pharmaceuticals segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the Select Industry Indices ), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ( GICS ).
Prospectus
Top 10 Holdings
DEFINIUM THERAPEUTICS INC DFTX 2.6992%
VIATRIS INC VTRS 2.3860%
ROYALTY PHARMA PLC CL A RPRX 2.3325%
MERCK + CO. INC. MRK 2.3184%
NEKTAR THERAPEUTICS NKTR 2.3172%
BRISTOL MYERS SQUIBB CO BMY 2.2901%
EDGEWISE THERAPEUTICS INC EWTX 2.2889%
PHIBRO ANIMAL HEALTH CORP A PAHC 2.2711%
SUPERNUS PHARMACEUTICALS INC SUPN 2.2655%
JOHNSON + JOHNSON JNJ 2.2347%
Top 10 Holdings Weight: 23.4%
Number of Holdings: 59
Shares Outstanding: 5,750,270
Total Net Assets: 325,522,800
NAV: 56.56
Net Expense Ratio: 0.35%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Pharmaceuticals
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged: No
US or Ex-US: Domestic
Market Data Delayed 15 Minutes